|
DE69329550T2
(en)
|
1992-07-13 |
2001-05-31 |
Cytomed, Inc. |
2,5-DIARYL TETRAHYDRO-THIOPENE, -FURANE AND ANALOGUE FOR THE TREATMENT OF INFLAMMATORY AND IMMUNE DISEASES
|
|
US5463083A
(en)
*
|
1992-07-13 |
1995-10-31 |
Cytomed, Inc. |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
US5434151A
(en)
*
|
1992-08-24 |
1995-07-18 |
Cytomed, Inc. |
Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
|
|
US5703093A
(en)
*
|
1995-05-31 |
1997-12-30 |
Cytomed, Inc. |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
US6201016B1
(en)
|
1994-06-27 |
2001-03-13 |
Cytomed Incorporated |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
US5750565A
(en)
*
|
1995-05-25 |
1998-05-12 |
Cytomed, Inc. |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
US5792776A
(en)
*
|
1994-06-27 |
1998-08-11 |
Cytomed, Inc., |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
DE19605766A1
(en)
*
|
1996-02-16 |
1997-08-21 |
Basf Ag |
Substituted 2-phenylpyridines
|
|
US6747027B1
(en)
|
1996-07-22 |
2004-06-08 |
Pharmacia Corporation |
Thiol sulfonamide metalloprotease inhibitors
|
|
EP0939628B1
(en)
*
|
1996-07-22 |
2003-03-05 |
Monsanto Company |
Thiol sulfone metalloprotease inhibitors
|
|
DE19719621A1
(en)
*
|
1997-05-09 |
1998-11-12 |
Hoechst Ag |
Sulfonylaminocarboxylic acids
|
|
US6800646B1
(en)
|
1999-02-08 |
2004-10-05 |
Pharmacia Corporation |
Sulfamato hydroxamic acid metalloprotease inhibitor
|
|
CA2417960C
(en)
|
2000-08-04 |
2012-07-10 |
Dmi Biosciences, Inc. |
Method of using diketopiperazines and composition containing them
|
|
US6645990B2
(en)
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
|
AU2003221786A1
(en)
|
2002-04-25 |
2003-11-10 |
Pharmacia Corporation |
Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
|
|
US7575929B2
(en)
|
2002-10-02 |
2009-08-18 |
Dmi Life Sciences, Inc. |
Diagnosis of multiple sclerosis with diketopiperazines
|
|
EP2537524B1
(en)
|
2003-05-15 |
2016-07-06 |
Ampio Pharmaceuticals, Inc. |
Treatment of T-cell mediated diseases
|
|
AP2007004161A0
(en)
|
2005-04-28 |
2007-10-31 |
Pfizer Ltd |
Amino acid derivatives
|
|
PT1919290E
(en)
|
2005-07-12 |
2014-03-20 |
Ampio Pharmaceuticals Inc |
Methods and products for treatment of diseases
|
|
WO2009146320A1
(en)
|
2008-05-27 |
2009-12-03 |
Dmi Life Sciences, Inc. |
Therapeutic methods and compounds
|
|
PL2554172T3
(en)
|
2009-06-22 |
2015-03-31 |
Ampio Pharmaceuticals Inc |
Method for treatment of diseases
|
|
WO2012033792A2
(en)
|
2010-09-07 |
2012-03-15 |
Dmi Acquisition Corp. |
Treatment of diseases
|
|
CN103841934A
(en)
|
2011-10-10 |
2014-06-04 |
安皮奥制药股份有限公司 |
Implantable medical devices for enhancing immune tolerance and methods of making and implanting the same
|
|
EP2766029B1
(en)
|
2011-10-10 |
2020-03-25 |
Ampio Pharmaceuticals, Inc. |
Treatment of degenerative joint disease
|
|
US10881710B2
(en)
|
2011-10-28 |
2021-01-05 |
Ampio Pharmaceuticals, Inc. |
Treatment of rhinitis
|
|
AU2013361338A1
(en)
|
2012-12-19 |
2015-08-06 |
Ampio Pharmaceuticals, Inc. |
Method for treatment of diseases
|
|
SG10201707619RA
(en)
|
2013-03-15 |
2017-10-30 |
Ampio Pharmaceuticals Inc |
Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
|
|
WO2016028790A1
(en)
|
2014-08-18 |
2016-02-25 |
Ampio Pharmaceuticals, Inc. |
Treatment of joint conditions
|
|
EP3310375A4
(en)
|
2015-06-22 |
2019-02-20 |
Ampio Pharmaceuticals, Inc. |
USE OF LOW MOLECULAR WEIGHT HUMAN SERUM ALBUMIN FRACTIONS FOR TREATING DISEASES
|